{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:18:54Z","timestamp":1787494734073,"version":"build-2736575974"},"reference-count":56,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The association between moyamoya disease (MMD) and hypertension has been studied as hospital-based case series without comparison to the general population. The aim of this study was to compare the prevalence and incidence of hypertension between pediatric patients with MMD and the general pediatric population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Data from the South Korea National Health Insurance Service was used to compare hypertension prevalence and incidence between pediatric patients with MMD (2008\u20132019) and the general pediatric population (2010). MMD was defined using ICD-10 code I67.5 and the Rare and Intractable Disease code V128. Hypertension was identified by ICD-10 codes I10\u2013I15 alongside antihypertensive medication claims. Prevalence and incidence rates were calculated for each year and age group (1\u20134, 5\u20139, 10\u201314, and 15\u201319 years). Indirect standardization was used to calculate prevalence and incidence rate ratios between the pediatric MMD cohort and the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The study included 3645 pediatric patients (2041 female, mean age 11.26 years) with MMD. Compared with the general pediatric population, there was a higher proportion of patients in the 5\u201314 years age range and more females in the MMD cohort. Chronic kidney disease, diabetes, renal artery stenosis, hyperthyroidism, and lupus were more prevalent comorbidities in patients with MMD. Hypertension prevalence and incidence were consistently higher in patients with MMD across all age groups. The standardized prevalence ratio was 43.79 (95% CI 40.56\u201347.01), indicating that patients with MMD had nearly 44 times higher prevalence of hypertension than expected. The standardized incidence ratio was 31.33 (95% CI 27.39\u201335.27), indicating that patients with MMD had approximately 31 times higher incidence of hypertension than expected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Pediatric patients with MMD in the Korean population have a significantly higher hypertension burden and risk, emphasizing the need for prioritized hypertension management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.10.peds25412","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:17:54Z","timestamp":1770430674000},"page":"421-428","source":"Crossref","is-referenced-by-count":1,"title":["Increased burden of systemic hypertension among pediatric patients with moyamoya disease: a population-based analysis of prevalence and incidence"],"prefix":"10.3171","volume":"37","author":[{"given":"Joongyub","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Seoul National University College of Medicine, Seoul;"},{"name":"National Heart and Stroke Center, Seoul National University Hospital, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Research Collaborating Center, Seoul National University Hospital\/Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Seoul National University Children\u2019s Hospital\/Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul National University Children\u2019s Hospital\/Seoul National University College of Medicine, Seoul; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"National Heart and Stroke Center, Seoul National University Hospital, Seoul;"},{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Whan","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Seoul National University Children\u2019s Hospital\/Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Seoul National University Children\u2019s Hospital\/Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Phi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Seoul National University Children\u2019s Hospital\/Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"Arch Neurol","first-page":"288","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u2013299. doi:10.1001\/archneur.1969.00480090076012"},{"issue":"1","key":"b2","series-title":"J Stroke","first-page":"2","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim JS","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311. doi:10.5853\/jos.2015.01627"},{"issue":"11","key":"b3","series-title":"Stroke","first-page":"1358","article-title":"Systemic vascular changes in spontaneous occlusion of the circle of Willis","volume":"22","author":"Ikeda E","year":"1991","unstructured":"Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke. 1991;22(11):1358\u20131362. doi:10.1161\/01.str.22.11.1358"},{"issue":"3","key":"b4","series-title":"Stroke","first-page":"733","article-title":"Renal artery lesions in patients with moyamoya disease: angiographic findings","volume":"31","author":"Yamada I","year":"2000","unstructured":"Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31(3):733\u2013737. doi:10.1161\/01.str.31.3.733"},{"issue":"1","key":"b5","series-title":"AJR Am J Roentgenol","first-page":"119","article-title":"Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease","volume":"183","author":"Togao O","year":"2004","unstructured":"Togao O, Mihara F, Yoshiura T,  Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183(1):119\u2013122. doi:10.2214\/ajr.183.1.1830119"},{"issue":"2","key":"b6","series-title":"J Neurosurg Pediatr","first-page":"131","article-title":"High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment","volume":"25","author":"Lee J","year":"2020","unstructured":"Lee J, Kim SK, Kang HG,  High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment. J Neurosurg Pediatr. 2020;25(2):131\u2013137. doi:10.3171\/2019.9.PEDS1986"},{"issue":"12","key":"b7","series-title":"JAMA Pediatr","first-page":"1154","article-title":"Global prevalence of hypertension in children: a systematic review and meta-analysis","volume":"173","author":"Song P","year":"2019","unstructured":"Song P, Zhang Y, Yu J,  Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154\u20131163. doi:10.1001\/jamapediatrics.2019.3310"},{"issue":"3","key":"b8","series-title":"Int J Epidemiol","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong S","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH,  Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799\u2013800. doi:10.1093\/ije\/dyw253"},{"issue":"5","key":"b9","series-title":"Diabetes Metab J","first-page":"395","article-title":"Background and data configuration process of a nationwide population-based study using the Korean national health insurance system","volume":"38","author":"Song SO","year":"2014","unstructured":"Song SO, Jung CH, Song YD,  Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab J. 2014;38(5):395\u2013403. doi:10.4093\/dmj.2014.38.5.395"},{"issue":"1","key":"b10","series-title":"Intractable Rare Dis Res","first-page":"3","article-title":"Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives","volume":"1","author":"Song P","year":"2012","unstructured":"Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012;1(1):3\u20139. doi:10.5582\/irdr.2012.v1.1.3"},{"issue":"2","key":"b11","series-title":"Am J Epidemiol","first-page":"407","article-title":"Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real world data","volume":"194","author":"Horgan CE","year":"2025","unstructured":"Horgan CE, Burk J, Eworuke E,  Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real world data. Am J Epidemiol. 2025;194(2):407\u2013419. doi:10.1093\/aje\/kwae233"},{"issue":"1","key":"b12","series-title":"Sci Rep","first-page":"7654","article-title":"Evaluation of administrative case definitions for hypertension in Canadian children","volume":"13","author":"Dart A","year":"2023","unstructured":"Dart A, Singer A, Chanchlani R, Ferguson T, Tangri N, Zappitelli M. Evaluation of administrative case definitions for hypertension in Canadian children. Sci Rep. 2023;13(1):7654. doi:10.1038\/s41598-023-33401-x"},{"issue":"1","key":"b13","series-title":"Clin Hypertens","first-page":"8","article-title":"Korea hypertension fact sheet 2020: analysis of nationwide population-based data","volume":"27","author":"Kim HC","year":"2021","unstructured":"Kim HC, Cho SMJ, Lee H, Lee HH, Baek J, Heo JE. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27(1):8. doi:10.1186\/s40885-021-00166-2"},{"issue":"1","key":"b14","series-title":"Open Heart","first-page":"e002640","article-title":"Review of codelists used to define hypertension in electronic health records and development of a codelist for research","volume":"11","author":"Massen GM","year":"2024","unstructured":"Massen GM, Stone PW, Kwok HHY,  Review of codelists used to define hypertension in electronic health records and development of a codelist for research. Open Heart. 2024;11(1):e002640. doi:10.1136\/openhrt-2024-002640"},{"issue":"35","key":"b15","series-title":"Eur Heart J","first-page":"3290","article-title":"Hypertension in children and adolescents","volume":"43","author":"de Simone G","year":"2022","unstructured":"de Simone G, Mancusi C, Hanssen H,  Hypertension in children and adolescents. Eur Heart J. 2022;43(35):3290\u20133301. doi:10.1093\/eurheartj\/ehac328]"},{"issue":"11","key":"b16","series-title":"J Clin Epidemiol","first-page":"1125","article-title":"The value and hazards of standardization in clinical epidemiologic research","volume":"41","author":"Chan CK","year":"1988","unstructured":"Chan CK, Feinstein AR, Jekel JF, Wells CK. The value and hazards of standardization in clinical epidemiologic research. J Clin Epidemiol. 1988;41(11):1125\u20131134. doi:10.1016\/0895-4356(88)90082-0"},{"issue":"4","key":"b17","series-title":"Nephron Clin Pract","first-page":"c322","article-title":"Stratification for confounding\u2014part 2: direct and indirect standardization","volume":"116","author":"Tripepi G","year":"2010","unstructured":"Tripepi G, Jager KJ, Dekker FW, Zoccali C. Stratification for confounding\u2014part 2: direct and indirect standardization. Nephron Clin Pract. 2010;116(4):c322\u2013325. doi:10.1159\/000319591"},{"issue":"10","key":"b18","series-title":"Stroke","first-page":"3124","article-title":"Association between the onset pattern of adult moyamoya disease and risk factors for stroke","volume":"51","author":"Hirano Y","year":"2020","unstructured":"Hirano Y, Miyawaki S, Imai H,  Association between the onset pattern of adult moyamoya disease and risk factors for stroke. Stroke. 2020;51(10):3124\u20133128. doi:10.1161\/STROKEAHA.120.030653"},{"issue":"2","key":"b19","series-title":"Cerebrovasc Dis Extra","first-page":"72","article-title":"Comparison of stroke risk factors between symptomatic and asymptomatic patients in a North American moyamoya disease cohort","volume":"12","author":"Kumar M","year":"2022","unstructured":"Kumar M, Larson A, Jabal MS,  Comparison of stroke risk factors between symptomatic and asymptomatic patients in a North American moyamoya disease cohort. Cerebrovasc Dis Extra. 2022;12(2):72\u201375. doi:10.1159\/000525098"},{"issue":"4","key":"b20","series-title":"Pediatrics","first-page":"e20180840","article-title":"Blood pressure elevation and risk of moyamoya syndrome in patients with trisomy 21","volume":"142","author":"Santoro JD","year":"2018","unstructured":"Santoro JD, Lee S, Mlynash M,  Blood pressure elevation and risk of moyamoya syndrome in patients with trisomy 21. Pediatrics. 2018;142(4):e20180840. doi:10.1542\/peds.2018-0840"},{"issue":"1","key":"b21","series-title":"J Hum Genet","first-page":"34","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A,  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. doi:10.1038\/jhg.2010.132"},{"issue":"7","key":"b22","series-title":"PLoS One","first-page":"e22542","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu W","year":"2011","unstructured":"Liu W, Morito D, Takashima S,  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6(7):e22542. doi:10.1371\/journal.pone.0022542"},{"issue":"2","key":"b23","series-title":"Environ Health Prev Med","first-page":"121","article-title":"P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure","volume":"18","author":"Koizumi A","year":"2013","unstructured":"Koizumi A, Kobayashi H, Liu W,  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013;18(2):121\u2013129. doi:10.1007\/s12199-012-0299-1"},{"issue":"6","key":"b24","series-title":"Hypertension","first-page":"1265","article-title":"Cerebrovascular variants and the role of the selfish brain in young-onset hypertension","volume":"79","author":"Manghat NE","year":"2022","unstructured":"Manghat NE, Robinson E, Mitrousi K,  Cerebrovascular variants and the role of the selfish brain in young-onset hypertension. Hypertension. 2022;79(6):1265\u20131274. doi:10.1161\/HYPERTENSIONAHA.121.18612"},{"issue":"3","key":"b25","series-title":"Pediatrics","first-page":"e20171904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn JT","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM,  Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. doi:10.1542\/peds.2017-1904"},{"issue":"6","key":"b26","series-title":"Hypertension","first-page":"1423","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan H","year":"2009","unstructured":"Quan H, Khan N, Hemmelgarn BR,  Validation of a case definition to define hypertension using administrative data. Hypertension. 2009;54(6):1423\u20131428. doi:10.1161\/HYPERTENSIONAHA.109.139279"},{"issue":"6 Pt 1","key":"b27","series-title":"Health Serv Res","first-page":"1839","article-title":"Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions","volume":"39","author":"Rector TS","year":"2004","unstructured":"Rector TS, Wickstrom SL, Shah M,  Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res. 2004;39(6 Pt 1):1839\u20131857. doi:10.1111\/j.1475-6773.2004.00321.x"},{"key":"b28","series-title":"BMC Public Health","first-page":"51","article-title":"Further validation that claims data are a useful tool for epidemiologic research on hypertension","volume":"13","author":"Tessier-Sherman B","year":"2013","unstructured":"Tessier-Sherman B, Galusha D, Taiwo OA,  Further validation that claims data are a useful tool for epidemiologic research on hypertension. BMC Public Health. 2013;13:51. doi:10.1186\/1471-2458-13-51"},{"issue":"3","key":"b1","series-title":"Arch Neurol","first-page":"288","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u2013299. doi:10.1001\/archneur.1969.00480090076012"},{"issue":"1","key":"b2","series-title":"J Stroke","first-page":"2","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim JS","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311. doi:10.5853\/jos.2015.01627"},{"issue":"11","key":"b3","series-title":"Stroke","first-page":"1358","article-title":"Systemic vascular changes in spontaneous occlusion of the circle of Willis","volume":"22","author":"Ikeda E","year":"1991","unstructured":"Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke. 1991;22(11):1358\u20131362. doi:10.1161\/01.str.22.11.1358"},{"issue":"3","key":"b4","series-title":"Stroke","first-page":"733","article-title":"Renal artery lesions in patients with moyamoya disease: angiographic findings","volume":"31","author":"Yamada I","year":"2000","unstructured":"Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31(3):733\u2013737. doi:10.1161\/01.str.31.3.733"},{"issue":"1","key":"b5","series-title":"AJR Am J Roentgenol","first-page":"119","article-title":"Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease","volume":"183","author":"Togao O","year":"2004","unstructured":"Togao O, Mihara F, Yoshiura T,  Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183(1):119\u2013122. doi:10.2214\/ajr.183.1.1830119"},{"issue":"2","key":"b6","series-title":"J Neurosurg Pediatr","first-page":"131","article-title":"High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment","volume":"25","author":"Lee J","year":"2020","unstructured":"Lee J, Kim SK, Kang HG,  High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment. J Neurosurg Pediatr. 2020;25(2):131\u2013137. doi:10.3171\/2019.9.PEDS1986"},{"issue":"12","key":"b7","series-title":"JAMA Pediatr","first-page":"1154","article-title":"Global prevalence of hypertension in children: a systematic review and meta-analysis","volume":"173","author":"Song P","year":"2019","unstructured":"Song P, Zhang Y, Yu J,  Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154\u20131163. doi:10.1001\/jamapediatrics.2019.3310"},{"issue":"3","key":"b8","series-title":"Int J Epidemiol","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong S","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH,  Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799\u2013800. doi:10.1093\/ije\/dyw253"},{"issue":"5","key":"b9","series-title":"Diabetes Metab J","first-page":"395","article-title":"Background and data configuration process of a nationwide population-based study using the Korean national health insurance system","volume":"38","author":"Song SO","year":"2014","unstructured":"Song SO, Jung CH, Song YD,  Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab J. 2014;38(5):395\u2013403. doi:10.4093\/dmj.2014.38.5.395"},{"issue":"1","key":"b10","series-title":"Intractable Rare Dis Res","first-page":"3","article-title":"Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives","volume":"1","author":"Song P","year":"2012","unstructured":"Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012;1(1):3\u20139. doi:10.5582\/irdr.2012.v1.1.3"},{"issue":"2","key":"b11","series-title":"Am J Epidemiol","first-page":"407","article-title":"Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real world data","volume":"194","author":"Horgan CE","year":"2025","unstructured":"Horgan CE, Burk J, Eworuke E,  Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real world data. Am J Epidemiol. 2025;194(2):407\u2013419. doi:10.1093\/aje\/kwae233"},{"issue":"1","key":"b12","series-title":"Sci Rep","first-page":"7654","article-title":"Evaluation of administrative case definitions for hypertension in Canadian children","volume":"13","author":"Dart A","year":"2023","unstructured":"Dart A, Singer A, Chanchlani R, Ferguson T, Tangri N, Zappitelli M. Evaluation of administrative case definitions for hypertension in Canadian children. Sci Rep. 2023;13(1):7654. doi:10.1038\/s41598-023-33401-x"},{"issue":"1","key":"b13","series-title":"Clin Hypertens","first-page":"8","article-title":"Korea hypertension fact sheet 2020: analysis of nationwide population-based data","volume":"27","author":"Kim HC","year":"2021","unstructured":"Kim HC, Cho SMJ, Lee H, Lee HH, Baek J, Heo JE. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27(1):8. doi:10.1186\/s40885-021-00166-2"},{"issue":"1","key":"b14","series-title":"Open Heart","first-page":"e002640","article-title":"Review of codelists used to define hypertension in electronic health records and development of a codelist for research","volume":"11","author":"Massen GM","year":"2024","unstructured":"Massen GM, Stone PW, Kwok HHY,  Review of codelists used to define hypertension in electronic health records and development of a codelist for research. Open Heart. 2024;11(1):e002640. doi:10.1136\/openhrt-2024-002640"},{"issue":"35","key":"b15","series-title":"Eur Heart J","first-page":"3290","article-title":"Hypertension in children and adolescents","volume":"43","author":"de Simone G","year":"2022","unstructured":"de Simone G, Mancusi C, Hanssen H,  Hypertension in children and adolescents. Eur Heart J. 2022;43(35):3290\u20133301. doi:10.1093\/eurheartj\/ehac328]"},{"issue":"11","key":"b16","series-title":"J Clin Epidemiol","first-page":"1125","article-title":"The value and hazards of standardization in clinical epidemiologic research","volume":"41","author":"Chan CK","year":"1988","unstructured":"Chan CK, Feinstein AR, Jekel JF, Wells CK. The value and hazards of standardization in clinical epidemiologic research. J Clin Epidemiol. 1988;41(11):1125\u20131134. doi:10.1016\/0895-4356(88)90082-0"},{"issue":"4","key":"b17","series-title":"Nephron Clin Pract","first-page":"c322","article-title":"Stratification for confounding\u2014part 2: direct and indirect standardization","volume":"116","author":"Tripepi G","year":"2010","unstructured":"Tripepi G, Jager KJ, Dekker FW, Zoccali C. Stratification for confounding\u2014part 2: direct and indirect standardization. Nephron Clin Pract. 2010;116(4):c322\u2013325. doi:10.1159\/000319591"},{"issue":"10","key":"b18","series-title":"Stroke","first-page":"3124","article-title":"Association between the onset pattern of adult moyamoya disease and risk factors for stroke","volume":"51","author":"Hirano Y","year":"2020","unstructured":"Hirano Y, Miyawaki S, Imai H,  Association between the onset pattern of adult moyamoya disease and risk factors for stroke. Stroke. 2020;51(10):3124\u20133128. doi:10.1161\/STROKEAHA.120.030653"},{"issue":"2","key":"b19","series-title":"Cerebrovasc Dis Extra","first-page":"72","article-title":"Comparison of stroke risk factors between symptomatic and asymptomatic patients in a North American moyamoya disease cohort","volume":"12","author":"Kumar M","year":"2022","unstructured":"Kumar M, Larson A, Jabal MS,  Comparison of stroke risk factors between symptomatic and asymptomatic patients in a North American moyamoya disease cohort. Cerebrovasc Dis Extra. 2022;12(2):72\u201375. doi:10.1159\/000525098"},{"issue":"4","key":"b20","series-title":"Pediatrics","first-page":"e20180840","article-title":"Blood pressure elevation and risk of moyamoya syndrome in patients with trisomy 21","volume":"142","author":"Santoro JD","year":"2018","unstructured":"Santoro JD, Lee S, Mlynash M,  Blood pressure elevation and risk of moyamoya syndrome in patients with trisomy 21. Pediatrics. 2018;142(4):e20180840. doi:10.1542\/peds.2018-0840"},{"issue":"1","key":"b21","series-title":"J Hum Genet","first-page":"34","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A,  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. doi:10.1038\/jhg.2010.132"},{"issue":"7","key":"b22","series-title":"PLoS One","first-page":"e22542","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu W","year":"2011","unstructured":"Liu W, Morito D, Takashima S,  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6(7):e22542. doi:10.1371\/journal.pone.0022542"},{"issue":"2","key":"b23","series-title":"Environ Health Prev Med","first-page":"121","article-title":"P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure","volume":"18","author":"Koizumi A","year":"2013","unstructured":"Koizumi A, Kobayashi H, Liu W,  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013;18(2):121\u2013129. doi:10.1007\/s12199-012-0299-1"},{"issue":"6","key":"b24","series-title":"Hypertension","first-page":"1265","article-title":"Cerebrovascular variants and the role of the selfish brain in young-onset hypertension","volume":"79","author":"Manghat NE","year":"2022","unstructured":"Manghat NE, Robinson E, Mitrousi K,  Cerebrovascular variants and the role of the selfish brain in young-onset hypertension. Hypertension. 2022;79(6):1265\u20131274. doi:10.1161\/HYPERTENSIONAHA.121.18612"},{"issue":"3","key":"b25","series-title":"Pediatrics","first-page":"e20171904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn JT","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM,  Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. doi:10.1542\/peds.2017-1904"},{"issue":"6","key":"b26","series-title":"Hypertension","first-page":"1423","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan H","year":"2009","unstructured":"Quan H, Khan N, Hemmelgarn BR,  Validation of a case definition to define hypertension using administrative data. Hypertension. 2009;54(6):1423\u20131428. doi:10.1161\/HYPERTENSIONAHA.109.139279"},{"issue":"6 Pt 1","key":"b27","series-title":"Health Serv Res","first-page":"1839","article-title":"Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions","volume":"39","author":"Rector TS","year":"2004","unstructured":"Rector TS, Wickstrom SL, Shah M,  Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res. 2004;39(6 Pt 1):1839\u20131857. doi:10.1111\/j.1475-6773.2004.00321.x"},{"key":"b28","series-title":"BMC Public Health","first-page":"51","article-title":"Further validation that claims data are a useful tool for epidemiologic research on hypertension","volume":"13","author":"Tessier-Sherman B","year":"2013","unstructured":"Tessier-Sherman B, Galusha D, Taiwo OA,  Further validation that claims data are a useful tool for epidemiologic research on hypertension. BMC Public Health. 2013;13:51. doi:10.1186\/1471-2458-13-51"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/37\/5\/article-p421.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/37\/5\/article-p421.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/37\/5\/article-p421.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:19:04Z","timestamp":1781187544000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/37\/5\/article-p421.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":56,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2025.10.peds25412","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}